159 related articles for article (PubMed ID: 35186599)
1. Cooccurrence of CD10-Positive and CD10-Negative Mantle Cell Lymphoma Complicated With Central Nervous System Involvement Solely by CD10-Positive Population.
Fukushima N; Mino T; Arihiro K; Ichinohe T
Cureus; 2022 Jan; 14(1):e21341. PubMed ID: 35186599
[TBL] [Abstract][Full Text] [Related]
2. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases.
Xu J; Medeiros LJ; Saksena A; Wang M; Zhou J; Li J; Yin CC; Tang G; Wang L; Lin P; Li S
Oncotarget; 2018 Feb; 9(14):11441-11450. PubMed ID: 29545910
[TBL] [Abstract][Full Text] [Related]
3. Blastoid Variant of Mantle Cell Lymphoma with Extranodal Presentation and Aberrant CD10 Expression.
Raman A; Jinkala SR; Murugan R; Manivannan P
Int J Appl Basic Med Res; 2024; 14(1):63-66. PubMed ID: 38504844
[TBL] [Abstract][Full Text] [Related]
4. A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology.
Sriganeshan V; Blom TR; Weissmann DJ
Arch Pathol Lab Med; 2008 Aug; 132(8):1346-9. PubMed ID: 18684040
[TBL] [Abstract][Full Text] [Related]
5. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
[TBL] [Abstract][Full Text] [Related]
6. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
7. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
8. A Push to Consider Mantle Cell Lymphoma in Adults with Leukemia/Lymphoma with Blastoid Morphology.
Arinze N; Omar N; Keruakous A; Kolhe R; Savage N
Hematol Rep; 2023 Oct; 15(4):592-596. PubMed ID: 37873796
[TBL] [Abstract][Full Text] [Related]
9. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of diagnosing mantle cell lymphoma and identifying its variants on fine-needle aspiration biopsy.
Foshat M; Stewart J; Khoury JD; Staerkel GA; Caraway NP
Cancer Cytopathol; 2019 Feb; 127(1):44-51. PubMed ID: 30452126
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
14. BCL6, MUM1, and CD10 expression in mantle cell lymphoma.
Gualco G; Weiss LM; Harrington WJ; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):103-8. PubMed ID: 19826251
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review.
Castillo DR; Park D; Jeon WJ; Joung B; Lee J; Yang C; Pham B; Hino C; Chong E; Shields A; Nguyen A; Brothers J; Liu Y; Zhang KK; Cao H
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373354
[TBL] [Abstract][Full Text] [Related]
16. Classical type and blastoid variant mantle cell lymphoma in the same lymph node: Histology and cytological findings from a touch imprint specimen.
Nakatsuka SI; Nagatomo T; Nagano T; Goto T; Hashimoto K
Diagn Cytopathol; 2017 Apr; 45(4):364-370. PubMed ID: 28140514
[TBL] [Abstract][Full Text] [Related]
17. Blastoid Variant Mantle Cell Lymphoma Expressing Aberrant CD3 and CD10 with Concurrent Small Lymphocytic Lymphoma: Establishment of a Clonal Relationship by B- and T-Cell Receptor Gene Rearrangements.
Felten CL; Chan JA; DeCastro DR; Lopategui J; Rajurkar SP
Case Rep Hematol; 2018; 2018():8303571. PubMed ID: 30627460
[TBL] [Abstract][Full Text] [Related]
18. CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.
Akhter A; Mahe E; Street L; Pournazari P; Perizzolo M; Shabani-Rad MT; Stewart DA; Mansoor A
J Clin Pathol; 2015 Oct; 68(10):844-8. PubMed ID: 26124315
[TBL] [Abstract][Full Text] [Related]
19. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
[TBL] [Abstract][Full Text] [Related]
20. Outcome prediction of advanced mantle cell lymphoma by international prognostic index versus different mantle cell lymphoma indexes: one institution study.
Todorovic M; Balint B; Andjelic B; Stanisavljevic D; Kurtovic NK; Radisavljevic Z; Mihaljevic B
Med Oncol; 2012 Sep; 29(3):2212-9. PubMed ID: 22170090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
